Imagine a world where kidney transplant rejection becomes a relic of the past, all thanks to an elixir of life crafted in a laboratory. While this may sound like the stuff of science fiction, our class project brings this tantalizing future one step closer to reality. Under the simulated company "Anti Biologics," based in the academic hub of Athens, GA, we explored the cutting-edge realm of monoclonal antibody production- and the numbers are jaw-dropping.

Our fictional facility efficiently produces 100 grams of these miraculous antibodies every day, using a meticulously engineered bioprocess involving murine myeloma cells and C5 immunized B cells. Following a cascade of steps- culturing, filtration, purification, and lyophilization- we extract a product so pure it could practically be considered medical gold.

And speaking of gold, let's talk economics. The production cost? A mere $20 per gram. The selling price? A staggering $800 per gram! Do the math, and you'll find a mind-boggling profit of $28.47 million per year. Soliris, our simulated competitor, had better watch out.

While this may be a classroom project, the science behind it is as real as it gets, with the potential to revolutionize organ transplants and make a profound impact on countless lives. Intrigued? Good, because this is merely a glimpse into a future teeming with medical miracles, and we can't wait to share more. Stay curious!